case presentation
play

Case Presentation Maha Akkawi, MD, Fatima Obeidat, MD, Tariq - PowerPoint PPT Presentation

Case Presentation Maha Akkawi, MD, Fatima Obeidat, MD, Tariq Aladily, MD Department of Pathology Jordan University Hospital Amman, Jordan The 25th Annual Congress of the ADIAP The 8/11/2013 1 5th International Conference of JSP Clinical


  1. Case Presentation Maha Akkawi, MD, Fatima Obeidat, MD, Tariq Aladily, MD Department of Pathology Jordan University Hospital Amman, Jordan The 25th Annual Congress of the ADIAP The 8/11/2013 1 5th International Conference of JSP

  2. Clinical Background • 39 year old smoker lady, presented with a 6 month history of toothache and headache • Medical history: hypertension The 25 th Annual Congress of the ADIAP 8/11/2013 2 The 5 th International Conference of JSP

  3. Clinical Background • Multiple visits to dental clinics, received pain killers but without relief • Visited an ENT clinic, physical exam revealed a nasal cavity mass • CT scan was performed The 25 th Annual Congress of the ADIAP 8/11/2013 3 The 5 th International Conference of JSP

  4. CT scan

  5. Radiologic findings • Large, lobulated, destructive solid tumor measuring 5 cm in maximum dimension, involving the roof of the mouth, the right nasal cavity, maxillary sinus, orbit • The tumor also extends to the right infratemporal fossa, ptregopalatine fossa and parapharyngeal space, sparing the oropharynx • The patient underwent endoscopic biopsy from the nasal mass The 25th Annual Congress of the ADIAP The 8/11/2013 5 5th International Conference of JSP

  6. 6

  7. 7

  8. 8

  9. 9

  10. 10

  11. 11

  12. 12

  13. Differential Diagnosis • Sarcoamtoid carcinoma(CK??) • Extracranial meningeoma (EMA, vimentin??) • Leiomyosarcoma ( Desmin, SMA??) • Solitary fibrous tumor (Bcl2, EMA??) • Anaplastic large cell lymphoma(CD30,CD45??) • Melanoma (HMB45??) The 25th Annual Congress of the ADIAP The 8/11/2013 13 5th International Conference of JSP

  14. cytokeratin 14

  15. vimentin 15

  16. CD45 16

  17. SMA 17

  18. Desmin 18

  19. S100 19

  20. EMA 20

  21. Bcl2 21

  22. CD30 22

  23. CD21 23

  24. CD23 24

  25. CD68 25

  26. Immunoprofile Positive Negative • • vimentin S100 • • CD21 CD45 • • CD23 CK • • CD68 (focal) EMA • SMA • Desmin • HMB45 • CD99 • Bcl2 • CD20 • CD30 • ALK • CD1a The 25th Annual Congress of the ADIAP The 8/11/2013 26 5th International Conference of JSP

  27. Diagnosis Extranodal follicular dendritic cell sarcoma The 25th Annual Congress of the ADIAP The 8/11/2013 27 5th International Conference of JSP

  28. FDC sarcoma • A rare neoplastic proliferation of FDCs (antigen-presenting immune accessory cells that are widely distributed in tissues) • First reported by Monda et al, in 1986 • Almost all patients are adults, with a median age of 40 years and with no sex predilection • Some association with Castleman disease (hyaline vascular variant) The 25th Annual Congress of the ADIAP The 8/11/2013 28 5th International Conference of JSP

  29. Etiology • Most cases: unknown • Hyaline-vascular Castleman disease (10-20%) of cases • A pathway for tumor evolution: FDC hyperplasia, dysplasia then transformation • Overexpression of p53 protein is noted in FDC sarcoma, and is weakly positive in spindle cells in Castleman disease • Epidermal growth factor receptor expression The 25th Annual Congress of the ADIAP The 8/11/2013 29 5th International Conference of JSP

  30. Clinical symptoms • Patients often present with a slow-growing, painless mass • Constitutional symptoms and paraneoplastic syndromes are rare, unless associated with Castleman disease, or in inflammatory pseudotumor variant of FDC sarcoma • Abdominal tumors present with pain and compression symptoms The 25th Annual Congress of the ADIAP The 8/11/2013 30 5th International Conference of JSP

  31. Nodal vs Extranodal sites • Nodal FDC sarcoma accounts for more than two thirds of cases, with cervical lymph nodes being the most commonly affected • Extranodal FDC sarcoma is very rare (37 cases by 2010)* • Most of the prototype: oropharynx • IPT-variant: spleen or liver • Other reported sites: GIT, soft tissue, skin, lung and breast * Duan GJ, Wu F, Zhu J, Guo DY, Zhang R, Shen LL, Wang SH, Li Q, Xiao HL, Mou JH, Yan XC, Extranodal follicular dendritic cell sarcoma of the pharyngeal region: a potential diagnostic pitfall, with literature review, Am j clin pathol, 2010 jan. 8/11/2013 31

  32. Gross features • Size range from 1 to 20 cm maximum diameter, with a median size of 6 cm • Round to ovoid, well- circumscribed, fleshy masses that on cut section are solid and tan • Interspersed areas of hemorrhage and yellowish necrotic areas might be present particularly in larger tumors The 25th Annual Congress of the ADIAP The 8/11/2013 32 5th International Conference of JSP

  33. Microscopic features • The tumor is characterized by a proliferation of spindle to ovoid cells that form fascicles, storiform patterns and whorls (360 o ) • Cells tend to be plump, with slightly eosinophilic, fibrillary cytoplasm and indistinct cell borders • The nuclei are elongated, unevenly spaced, small distinct nucleoli • Occasional nuclear pseudoinclusions The 25th Annual Congress of the ADIAP The 8/11/2013 33 5th International Conference of JSP

  34. Microscopic features • Small lymphocytes are scattered throughout the tumor and perivascular cuffing • Occasional binucleated and multinucleated tumor cells may be present • Although highly cellular, atypia is only mild to moderate • Mitotic figures: 0-10/ 10HPF • Necrosis can be seen in higher grade tumors The 25th Annual Congress of the ADIAP The 8/11/2013 34 5th International Conference of JSP

  35. IPT variant • Spleen or liver • Prominent lymphoplasmacytic infiltrate, masking neoplastic cells • Atypia is more variable within the tumor • Necrosis and hemorrhage are more common • EBV positive (EBER-ISH) • More aggressive The 25th Annual Congress of the ADIAP The 8/11/2013 35 5th International Conference of JSP

  36. Immunophenotype • Normal FDC antigens: CD21, CD35, CD23, D2-40, CXCL-13 • Common positivity: vimentin, fascin, desmoplakin, HLA-DR, EGFR, CD4 • Variable positivity: CD68, S100, EMA, CD15 • Negative: CD45, CD20, CD1a, lysozyme, MPO, CD34, CD3, CD79a, CD30, HMB-45, CK • Clusterin: sensitive and specific • Ki-67 index: 1-25% The 25th Annual Congress of the ADIAP The 8/11/2013 36 5th International Conference of JSP

  37. Treatment • The current approach is to apply therapeutic guidelines similar to those used for soft tissue sarcomas of high grade • Complete surgical resection is the therapy of choice • Adjuvant radiation or chemotherapy decreases the rate of recurrence The 25th Annual Congress of the ADIAP The 8/11/2013 37 5th International Conference of JSP

  38. Biologic behavior and Prognosis • The behavior of these tumors is more akin to that of a low-grade soft tissue sarcoma than a malignant lymphoma • Local recurrences rate: 36%, metastasis : 28%, mostly to LN and liver Poor prognostic factors :  intra-abdominal location  s ize ≥ 6 cm  mitotic count ≥ 5 /10 HPFs  coagulative necrosis  significant nuclear pleomorphism The 25th Annual Congress of the ADIAP The 8/11/2013 38 5th International Conference of JSP

  39. Message? • As spindle cell tumors within lymph nodes are rare, the diagnosis of FDCS within a node is not that difficult. However, extranodal FDCS cases are much more challenging in diagnosis because sarcomatoid carcinoma and sarcoma are by far much more common • Clue: morphologic features The 25th Annual Congress of the ADIAP The 8/11/2013 39 5th International Conference of JSP

  40. Our patient • Patient still alive with disease • Receiving radiotherapy... • No surgery yet…. The 25th Annual Congress of the ADIAP The 8/11/2013 40 5th International Conference of JSP

Recommend


More recommend